NCT02405689View on ClinicalTrials.gov

Myocardial Protection and Anesthetic Agents

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Myocardial Ischemic Reperfusion Injury
Interventions
DRUG

Remifentanil

DRUG

Dexmedetomidine

DRUG

Sevoflurane

Trial Locations (1)

01130

Cukurova University, Adana

All Listed Sponsors
lead

Cukurova University

OTHER

NCT02405689 - Myocardial Protection and Anesthetic Agents | Biotech Hunter | Biotech Hunter